Iliopsoas hematoma in patients with COVID-19 on low-molecular-weight heparin treatment.
SAGE Open Med Case Rep
; 9: 2050313X211016991, 2021.
Article
in English
| MEDLINE | ID: covidwho-1262440
ABSTRACT
Patients with COVID-19 are at high risk of thromboembolic events; for this reason, the use of heparin is largely recommended but, in addition to thrombotic complications, bleeding is a significant cause of morbidity in patients with COVID-19. Idiopathic iliopsoas hematoma is a very rarely described hemorrhagic complication in patients with COVID-19. We report here two cases of iliopsoas hematoma in male patients with COVID-19 and being treated with heparin.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
SAGE Open Med Case Rep
Year:
2021
Document Type:
Article
Affiliation country:
2050313X211016991
Similar
MEDLINE
...
LILACS
LIS